EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid—In Silico and In Vitro Study

Ewa Bębenek iD, Zuzanna Rzepka iD, Justyna Magdalena Hermanowicz iD, Elwira Chrobak iD, Arkadiusz Surażyński iD, Artur Beberok iD, Dorota Wrześniok iD

International Journal of Molecular Sciences · 20.04.2024 · 25 (8) · 4517

DOI: 10.3390/ijms25084517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.04.2024. Verfasst von Ewa Bębenek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska, 41-200 S…. Hauptthemen laut MEDLINE: Amides, Antineoplastic Agents, Zebrafish, Oleanolic Acid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Univeristy of Silesia in Katowice, Medical University of Silesia in Katowice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Betulonic acid (B(O)A) is a pentacyclic lupane-type triterpenoid that widely exists in plants. There are scientific reports indicating anticancer activity of B(O)A, as well as the amides and esters of this triterpenoid. In the first step of the study, the synthesis of novel amide derivatives of B(O)A containing an acetylenic moiety was developed. Subsequently, the medium-soluble compounds (EB171 and EB173) and the parent compound, i.e., B(O)A, were investigated for potential cytotoxic activity against breast cancer (MCF-7 and MDA-MB-231) and melanoma (C32, COLO 829 and A375) cell lines, as well as normal human fibroblasts. Screening analysis using the WST-1 test was applied. Moreover, the lipophilicity and ADME parameters of the obtained derivatives were determined using experimental and in silico methods. The toxicity assay using zebrafish embryos and larvae was also performed. The study showed that the compound EB171 exhibited a significant cytotoxic effect on cancer cell lines: MCF-7, A-375 and COLO 829, while it did not affect the survival of normal cells. Moreover, studies on embryos and larvae showed no toxicity of EB171 in an animal model. Compared to EB171, the compound EB173 had a weaker effect on all tested cancer cell lines and produced less desirable effects against normal cells. The results of the WST-1 assay obtained for B(O)A revealed its strong cytotoxic activity on the examined cancer cell lines, but also on normal cells. In conclusion, this article describes new derivatives of betulonic acid—from synthesis to biological properties. The results allowed to indicate a promising direction for the functionalization of B(O)A to obtain derivatives with selective anticancer activity and low toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmidesAntineoplastic AgentsZebrafishOleanolic AcidBetulinic AcidHumansAnimalsCell Line, TumorComputer SimulationMCF-7 CellsCell Survival

Stichwörter der Autor:innen

anticancer potentialbetulonic acidbreast cancermelanoma

Substanzen

betulonic acidAmidesAntineoplastic AgentsOleanolic AcidBetulinic Acid

Autor:innen und Institutionen

  • Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska, 41-200 Sosnowiec, Poland.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska, 41-200 Sosnowiec, Poland.
  • Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland.
  • Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland.
  • Department of Medicinal Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland.

ORCID-Profile: Ewa Bębenek, Zuzanna Rzepka, Justyna Magdalena Hermanowicz, Elwira Chrobak, Arkadiusz Surażyński, Artur Beberok, Dorota Wrześniok

Förderung

  • Medical Univeristy of Silesia in Katowice
  • Medical University of Silesia in Katowice

Zitieren

APA

Bębenek, E., Rzepka, Z., Hermanowicz, J. M., Chrobak, E., Surażyński, A., Beberok, A., & Wrześniok, D. (2024). Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid—In Silico and In Vitro Study. International Journal of Molecular Sciences, 25(8), 4517. https://doi.org/10.3390/ijms25084517

Vancouver

Bębenek E, Rzepka Z, Hermanowicz JM, Chrobak E, Surażyński A, Beberok A, et al. Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid—In Silico and In Vitro Study. International Journal of Molecular Sciences. 2024;25(8):4517. doi:10.3390/ijms25084517

BibTeX
@article{Bbenek2024,
  author = {Bębenek, Ewa and Rzepka, Zuzanna and Hermanowicz, Justyna Magdalena and Chrobak, Elwira and Surażyński, Arkadiusz and Beberok, Artur and Wrześniok, Dorota},
  title = {Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid—In Silico and In Vitro Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {8},
  pages = {4517},
  doi = {10.3390/ijms25084517}
}
Kostenlos starten →